These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10498614)

  • 1. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
    Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Wessels H; de Witte T
    Blood; 1999 Oct; 94(7):2414-23. PubMed ID: 10498614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
    Pallis M; Turzanski J; Langabeer S; Russell NH
    Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
    Hu XF; Slater A; Kantharidis P; Rischin D; Juneja S; Rossi R; Lee G; Parkin JD; Zalcberg JR
    Blood; 1999 Jun; 93(12):4086-95. PubMed ID: 10361105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
    Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
    Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
    Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity.
    Smeets M; Raymakers R; Vierwinden G; Pennings A; van de Locht L; Wessels H; Boezeman J; de Witte T
    Br J Haematol; 1997 Feb; 96(2):346-55. PubMed ID: 9029024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the treatment of acute myeloid leukemia.
    Smeets M; de Witte T; van der Lely N; Raymakers R; Muus P
    Adv Exp Med Biol; 1999; 457():557-65. PubMed ID: 10500834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.
    Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia.
    Marcelletti JF; Sikic BI; Cripe LD; Paietta E
    Cytometry B Clin Cytom; 2019 Jan; 96(1):57-66. PubMed ID: 30334334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.
    Motomura S; Motoji T; Takanashi M; Wang YH; Shiozaki H; Sugawara I; Aikawa E; Tomida A; Tsuruo T; Kanda N; Mizoguchi H
    Blood; 1998 May; 91(9):3163-71. PubMed ID: 9558371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
    Raaijmakers MH; de Grouw EP; van der Reijden BA; de Witte TJ; Jansen JH; Raymakers RA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3452-8. PubMed ID: 16740770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the protein kinase C inhibitor staurosporine on chemosensitivity to daunorubicin of normal and leukemic fresh myeloid cells.
    Laredo J; Huynh A; Muller C; Jaffrézou JP; Bailly JD; Cassar G; Laurent G; Demur C
    Blood; 1994 Jul; 84(1):229-37. PubMed ID: 7912555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
    Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
    Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
    Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
    Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
    Elgie AW; Sargent JM; Williamson CJ; Lewandowicz GM; Taylor CG
    Adv Exp Med Biol; 1999; 457():29-33. PubMed ID: 10500777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
    Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.